<DOC>
	<DOCNO>NCT01765023</DOCNO>
	<brief_summary>The purpose study assess pharmacokinetic interaction atorvastatin metformin single co-administered healthy volunteer</brief_summary>
	<brief_title>Pharmacokinetic Interactions Between Atorvastatin Metformin Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Willing adhere protocol requirement sign inform consent form 2 . Healthy male volunteer age range 2055 year weight range exceed Â±20 % ideal weight . Ideal weight = [ height 100 ] *0.9 3 . Subjects history significant chronic disease 4 . Judged good health basis vital sign , ECG , physical exam routine laboratory data trial investigator 1 . Subjects take inducer inhibitor drug metabolism enzyme barbital within 28days prior study medication dose 2 . Subjects Symptoms acute disease within 28days prior study medication dose 3 . Subjects history gastrointestinal disease might significantly change ADME medicine 4 . Subjects history abdominal surgery within food water limit 5 . Subjects history clinically significant allergy include drug allergy 6 . Subjects anaphylaxis atorvastatin and/or metformin 7 . Subjects history plan iodine radiotherapy within 28 day prior drug administration 8 . Subjects history myopathy 9 . Subjects hereditary problem , example , galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption 10 . Clinical laboratory test value outside accept normal range AST ALT &gt; 1.25 time normal range Total bilirubin &gt; 1.5 time normal range Creatinine clearance &lt; 90 mL/min 11 . Subjects history drug , caffeine alcohol abuse ( caffeine &gt; 5cups/day , cigarette &gt; 10/day , alcohol &gt; 30g/day ) ever drink within 7 day prior drug administration 12 . Special diet know interfere absorption , distribution , metabolism excretion drug ( especially , consumption grapefruit juice ) within 7 day prior drug administration 13 . Donated blood within 60 day prior dose 14 . Participated previous clinical trial within 60 day prior dose 15 . Subjects receive drug might confound result trial base medical judgement investigator within 10days prior drug administration 16 . Subjects consider unsuitable base medical judgement investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>